Key Metrics
CiteScore 

7.8
H-Index 

35
Impact Factor 

5 - 10
SJR 

Q1Pharmacology (medical)

SNIP 

1.61
Recommended pre-submission checks
Powered by 

Topics Covered on European Heart Journal - Cardiovascular Pharmacotherapy
European Heart Journal - Cardiovascular Pharmacotherapy Journal Specifications
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in European Heart Journal - Cardiovascular Pharmacotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in European Heart Journal - Cardiovascular Pharmacotherapy
Why does research integrity affect us all?
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Correction to: Cardiovascular pharmacotherapy in 2025.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Response to SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Innovation and constraints in cardiovascular pharmacotherapy.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Cardiovascular pharmacotherapy in 2025.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Why does research integrity affect us all?
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Correction to: Cardiovascular pharmacotherapy in 2025.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Response to SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Innovation and constraints in cardiovascular pharmacotherapy.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Cardiovascular pharmacotherapy in 2025.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
FAQs on European Heart Journal - Cardiovascular Pharmacotherapy
How long has European Heart Journal - Cardiovascular Pharmacotherapy been actively publishing? 
What is the publishing frequency of European Heart Journal - Cardiovascular Pharmacotherapy? 
How many articles did European Heart Journal - Cardiovascular Pharmacotherapy publish last year? 
What is the eISSN & pISSN for European Heart Journal - Cardiovascular Pharmacotherapy? 
What is Citescore for European Heart Journal - Cardiovascular Pharmacotherapy? 
What is the H Index for European Heart Journal - Cardiovascular Pharmacotherapy ? 
What is SNIP score for European Heart Journal - Cardiovascular Pharmacotherapy? 
What is the SJR for European Heart Journal - Cardiovascular Pharmacotherapy? 
Who is the publisher of European Heart Journal - Cardiovascular Pharmacotherapy? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary